Anatara Lifesciences Limited (ASX:ANR) Webinar on the Company's Stage 1 Irritable Bowel Syndrome

Anatara Lifesciences (ASX:ANR) is pleased to invite shareholders, investors and interested parties to an online Webinar on the Company's Stage 1 Irritable Bowel Syndrome (IBS) clinical trial results, hosted by Chair, Dr. David Brookes.

Related Keywords

Sydney ,New South Wales ,Australia ,Anatara Lifesciences ,David Brookes ,Company Stage ,Anatara Lifesciences Limited ,Bowel Syndrome ,Lifesciences Limited ,Biotech ,Drugs Otc ,Health Pharm Generalanatara Lifesciences Limited ,Asx Anr ,